Genes, Vol. 15, Pages 538: Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine

Genes, Vol. 15, Pages 538: Colorectal Cancer: Genetic Underpinning and Molecular Therapeutics for Precision Medicine Genes doi: 10.3390/genes15050538 Authors: Gideon T. Dosunmu Ardaman Shergill Colorectal cancer (CRC) accounts for about 10% of all cancer cases and 9% of cancer-related deaths globally. In the United States alone, CRC represents approximately 12.6% of all cancer cases, with a mortality rate of about 8%. CRC is now the first leading cause of cancer death in men younger than age 50 and second in women younger than age 50. This review delves into the genetic landscape of CRC, highlighting key mutations and their implications in disease progression and treatment. We provide an overview of the current and emerging therapeutic strategies tailored to individual genomic profiles.
Source: Genes - Category: Genetics & Stem Cells Authors: Tags: Review Source Type: research